Filtern
Gehört zur Bibliographie
- ja (155)
Erscheinungsjahr
Dokumenttyp
Schlagworte
- heart failure (16)
- echocardiography (9)
- Herzinsuffizienz (8)
- cardiomyopathy (6)
- magnetic resonance imaging (6)
- mitochondria (6)
- acute heart failure (5)
- myocardial infarction (5)
- prognosis (5)
- akute Herzinsuffizienz (4)
- atrial fibrillation (4)
- cardiovascular genetics (4)
- ischemic stroke (4)
- mortality (4)
- Barth syndrome (3)
- Herzhypertrophie (3)
- Herzmuskelkrankheit (3)
- MRI (3)
- Magnetic resonance imaging (3)
- chronic heart failure (3)
- deep learning (3)
- desmin (3)
- hypertension (3)
- radial (3)
- reactive oxygen species (3)
- 7 T (2)
- 7T (2)
- Arrhythmie (2)
- Beschleunigungssensor (2)
- CRISPR/Cas9 (2)
- Chronotrope Inkompetenz (2)
- DSG2 (2)
- EUROASPIRE (2)
- Fabry disease (2)
- Fluoreszenz (2)
- GFAP (2)
- Guidelines (2)
- Heart failure (2)
- Herzfrequenz (2)
- Herzmuskelzelle (2)
- Herzschrittmacher (2)
- Induzierte pluripotente Stammzelle (2)
- Koronare Herzkrankheit (2)
- Mitochondrium (2)
- Natrium-Calcium-Austauscher (2)
- Pulswelle (2)
- Quality of life (2)
- TRP-Kanäle (2)
- TRPC4 (2)
- accelerometer-sensor (2)
- anxiety (2)
- arrhythmia (2)
- arrhythmogenic cardiomyopathy (2)
- atherosclerosis (2)
- biomarkers (2)
- carbohydrates (2)
- cardiac (2)
- cardiac device (2)
- cardiac magnetic resonance (2)
- cardiac magnetic resonance imaging (2)
- cardiac metabolism (2)
- cardiogenetics (2)
- cardiolipin (2)
- cardiology (2)
- cardiovascular diseases (2)
- cardiovascular implantable electronic device (2)
- cardiovascular risk factors (2)
- chronotropic incompetence (2)
- cognitive impairment (2)
- coronary heart disease (2)
- depression (2)
- desmosomes (2)
- diabetes mellitus (2)
- diffusion tensor imaging (2)
- dilated cardiomyopathy (2)
- ejection fraction (2)
- glial fibrillary acidic protein (2)
- heart (2)
- heart rate (2)
- inflammation (2)
- internal medicine (2)
- left ventricular ejection fraction (2)
- mapping (2)
- morbidity (2)
- mouse (2)
- myocardial work (2)
- neural networks (2)
- norepinephrine transporter (2)
- positron emission tomography (2)
- quality (2)
- quality of life (2)
- regulatory T cells (2)
- respiratory chain (2)
- restrictive cardiomyopathy (2)
- secondary prevention (2)
- segmentation (2)
- theranostics (2)
- thorax (2)
- translational research (2)
- troponin (2)
- whole exome sequencing (2)
- 3D echocardiography (1)
- 3D printing (1)
- 3 T (1)
- 4D flow MRI (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- ACC/AHA classification (1)
- ACM (1)
- AHF (1)
- AHF-Register Würzburg (1)
- AI (1)
- ARVC (1)
- ASE formula (1)
- Acylcarnitin (1)
- Addison's disease (1)
- Alzheimer's disease (1)
- Angiotensin II (1)
- Aorta (1)
- Aortenklappe (1)
- Arrhythmogene Kardiomyopathie (1)
- Arrhythmogenic cardiomyopathy (1)
- Arterielle Gefäßsteifigkeit (1)
- Arteriosklerose (1)
- Asthma (1)
- Atherosclerosis (1)
- B (1)
- B-MYB (1)
- B0 (1)
- BDNF (1)
- Barth Syndrome (1)
- Bildgebendes Verfahren (1)
- Biobank (1)
- Bioluminescence (1)
- Blood pressure (1)
- Brain atrophy (1)
- Breathing (1)
- Brownian ratchet (1)
- Bypass (1)
- CD4+ T-cells (1)
- CMR (1)
- COVID-19 (1)
- CRISPR-Cas Systems (1)
- CRISPR/Cas-Methode (1)
- CXCR4 (1)
- Calcium (1)
- Calciumkanal (1)
- Calciumtransport (1)
- Calpain (1)
- Cardiac (1)
- Cardiac Efficiency (1)
- Cardiac MRI (1)
- Cardiac ventricles (1)
- CardioMEMS™ HF system (1)
- CardioMEMS™ HF-System (1)
- Cardiovascular disease (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic-resonance (1)
- Carotis Intima Media Dicke (1)
- Cavβ subunit (1)
- Cerebral-ischemia (1)
- Chronic heart failure (1)
- Chronic heart-failure (1)
- Chronic kidney disease (1)
- Chronic obstrusive pulmonary disease (1)
- Chronische Herzinsuffizienz (1)
- Chronische Nierenerkrankung (1)
- Clinical decision support system (1)
- Clinically silent stroke (1)
- Cognitive decline (1)
- Cognitive impairment (1)
- Collaboration (1)
- Coronary artery disease (1)
- Coronary heart disease (1)
- Cotransporter 2 inhibition (1)
- Cranial sutures (1)
- DSC2 (1)
- DTI (1)
- Data acquisition (1)
- Deep learning (1)
- Diagnostic medicine (1)
- Diffusion tensor imaging (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Dilated Cardiomyopathy with Ataxia (1)
- Diseases (1)
- Dokumentationsqualität (1)
- Double-blind (1)
- E/e’ (1)
- ERK1/2 (1)
- Echocardiography (1)
- Echokardiographie (1)
- Echtes WRF (1)
- Eigenvectors (1)
- Embryos (1)
- Endorganschaden (1)
- English version (1)
- Enhancer elements (1)
- Entscheidungsunterstützungssystem (1)
- Enzyme replacement therapy (1)
- Excitation-Transcription-Coupling (1)
- Extracellular volume (1)
- FKBP52 (1)
- Fabry Disease (FD) (1)
- Fabry-associated pain (1)
- Friedreich’s ataxia (1)
- GDNF (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Gefäßalter (1)
- Genanalyse (1)
- Germany (1)
- Glatiramer acetate (1)
- Glial fibrillary acidic protein (1)
- HFpEF (1)
- HMDP hydroxymethylene diphosphonate (1)
- Head-injury (1)
- Heart (1)
- Heart Failure (1)
- Hemodynamic depression (1)
- Herzdekompensation (1)
- Herzthoraxchirurgie (1)
- Hesse (1)
- HiGHmed (1)
- Hindbrain (1)
- Hospitalization (1)
- Hypertension (1)
- Hypertrophic cardiomyopathy (1)
- Hämodialyse (1)
- IP3 signaling (1)
- IP3-Signaling (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunologie (1)
- Immunophilin (1)
- Induced Pluripotent Stem Cells (1)
- Inflammation (1)
- Inositoltrisphosphat (1)
- Integrated Palliative care outcome scale (1)
- Intensivtransport (1)
- Interhospitaltransfer (1)
- Intravascular coagulation (1)
- Journal of Nuclear Cardiology (1)
- KHK (1)
- KWIC (1)
- Kandidatengen (1)
- Kardiologie (1)
- Kernspintomografie (1)
- Kognitive Defizite (1)
- Kreatinin (1)
- Künstliche Intelligenz (1)
- L-type calcium channels (1)
- LMNA (1)
- LTCC-independent function of Cavβ (1)
- LV Function (1)
- LV dilatation (1)
- LVNC (1)
- Langzeitbeatmung (1)
- Langzeitlagerung (1)
- Lebensqualität (1)
- Long COVID (1)
- MOLLI (1)
- Management (1)
- Manifestation (1)
- Massive parallele Sequenzierung (1)
- Measurement (1)
- Medicine (1)
- Mellitus (1)
- Memory dysfunction (1)
- Mice (1)
- MitoQ (1)
- Mitochondrialer Uniporter (MCU) (1)
- Mitochondrialer Uniporter Knock out (MCU-KO) (1)
- Mitofusin2 (1)
- MitraClip (1)
- Model (1)
- Molecular-weight heparin (1)
- Mortality (1)
- Mortalität (1)
- Mouse models (1)
- Mutation (1)
- Myb-MuvB (1)
- Myocardial Work (1)
- Myocardial fibrosis (1)
- Myocardial infarction (1)
- Myocardial-perfusion SPECT (1)
- Myokardinfarkt (1)
- NEC (1)
- NET (1)
- NOAC (1)
- NSG animals (1)
- NT-proBNP (1)
- NT‐proBNP (1)
- Na+/K+-ATPase (1)
- Natrium-Kalium-Pumpe (1)
- Neurodegeneration (1)
- Neurons (1)
- NfL (1)
- Niereninsuffizienz (1)
- OXPHOS (1)
- Oxygen (1)
- PKA (1)
- PKP2 (1)
- PWV (1)
- Pain questionnaire (1)
- Palliativmedizin (1)
- Placebo-controlled trial (1)
- Plasma (1)
- Prevalence (1)
- Prognostic impact (1)
- Protons (1)
- Pseudo-WRF (1)
- Pulmonary imaging (1)
- RKIP (1)
- ROS (1)
- Raman micro-spectroscopy (1)
- Rats (1)
- Risiko (1)
- Risk-factors (1)
- Röntgen-Thorax (1)
- S-glutathionylation (1)
- SAR safety (1)
- SASHA (1)
- SF-36 (1)
- SGLT2 inhibitors (1)
- SPECT (1)
- SR/Mitochondriales Feedback (1)
- ST-elevation myocardial infarction (1)
- STAAB Cohort Study (1)
- STEMI (1)
- Sars-CoV-2 (1)
- Scar (1)
- Score (1)
- Segmentation (1)
- Selbstwirksamkeit (1)
- Self-efficacy (1)
- Sengers syndrome (1)
- Septal bulge (1)
- Serum (1)
- ShMOLLI (1)
- Shimming (1)
- Skull (1)
- Somites (1)
- Spironolacton (1)
- Stabilität (1)
- Sterblichkeit (1)
- Stiffness (1)
- Stoffwechsel (1)
- Stroke (1)
- Survival (1)
- Swine (1)
- Systole (1)
- T cells (1)
- T-shaped π–π stacking (1)
- T1 mapping (1)
- T1rho (1)
- T1ρ (1)
- TMEM43 (1)
- TRPC (1)
- TRPC-Ionenkanäle (1)
- TT\(_{1rho}\) mapping (1)
- T\(_{1P}\) dispersion (1)
- T\(_{1P}\) mapping (1)
- Tabakkonsum (1)
- Tandem-Peptid (1)
- Task force (1)
- Teichholz formula (1)
- Thrombus formation (1)
- Time measurement (1)
- Tobacco smoking (1)
- Tractography (1)
- Ultrahigh field (1)
- VARS2 (1)
- Valvular heart-desease (1)
- Vaskuläre Funktion (1)
- Ventricular-arrhythmias (1)
- Verdachtsgenerierung (1)
- Versorgungsforschung (1)
- Versorgungsprogramm (1)
- WSS (1)
- Wasted Work (1)
- Weaning (1)
- Weight (1)
- YAP (1)
- Zebrafish (1)
- acid sphingomyelinase (1)
- acute decompensated heart failure (1)
- adaptive immune response (1)
- adverse effects (1)
- age-related hearing loss (1)
- akute Niereninsuffizienz (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- amyloid cardiomyopathy (1)
- amyloidosis (1)
- anaemia (1)
- aneurysm (1)
- antenna (1)
- anti-myocardial (1)
- antibody/autoantibody (1)
- anticoagulation (1)
- antidepressants (1)
- antithrombotic therapy (1)
- anxious depression (1)
- aortic arch (1)
- aortic valve stenosis (1)
- areas (1)
- arterial stiffening (1)
- augmentation (1)
- autoantibody (1)
- basic (1)
- blood coagulation factor XIII (1)
- blood plasma (1)
- blood pressure (1)
- blood pressure monitoring (1)
- blood–brain barrier (1)
- blood–labyrinth barrier (1)
- body (1)
- bolus-based perfusion measurement (1)
- bridging (1)
- cadherins (1)
- calcification (1)
- calcium cycling (1)
- calcium imaging (1)
- calcium signaling (1)
- cancer (1)
- cancer treatment (1)
- candidate genes (1)
- cardiac MRI (1)
- cardiac arrest (1)
- cardiac function (1)
- cardiac imaging (1)
- cardiac training group (1)
- cardioprotective potential (1)
- cardiovascular MR methods (1)
- cardiovascular MRI (1)
- cardiovascular drugs (1)
- cardiovascular magnetic resonance (1)
- cardiovascular magnetic resonance (CMR) (1)
- care tempis (1)
- carotid artery disease (1)
- case report (1)
- catecholamines (1)
- cell biology (1)
- cell staining (1)
- cerebral microbleeds (1)
- channel transport (1)
- chest-x-ray (1)
- cholesterol (1)
- chronic kidney disease (1)
- clinical data warehouse (1)
- clinical routine data (1)
- clinical study (1)
- clinical systems (1)
- cluster analysis (1)
- cognitive decline (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- comorbidity (1)
- comparability (1)
- computational fluid dynamics (1)
- computed tomography (1)
- conformational auto-epitope (1)
- congestion (1)
- contractility (1)
- coronary arteries (1)
- coronary artery bypass grafting (1)
- coronary artery disease (1)
- correction (1)
- cross-cultural comparison (1)
- cyclic peptides/cyclopeptides (1)
- cyclopeptide therapy (1)
- cytokines (1)
- cytotoxic T cells (1)
- data acquisition (1)
- death rates (1)
- deformation (1)
- dementia (1)
- density (1)
- depressive disorder (1)
- design (1)
- desmin-related myopathy (1)
- desminopathy (1)
- desmocollin-2 (1)
- desmoglein-2 (1)
- desmosomal mutations (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- diastolic function (1)
- diet (1)
- digital Health (1)
- dilated cardiomyopathy with ataxia (1)
- dilated cardiomyopathy with ataxia (DCMA) (1)
- disease score (1)
- disease severity (1)
- documentation quality (1)
- drug interaction (1)
- drug intoxication (1)
- drug toxicity (1)
- eGFR (1)
- echo planar imaging (1)
- editorial (1)
- elamipretide (1)
- electromagnetics (1)
- electronic data capture (1)
- electronic health records (1)
- electrophysiology (1)
- element (1)
- endovascular treatment (1)
- enhancer (1)
- entropy production (1)
- evidence-based practice (1)
- expert opinion (1)
- fatty acids (1)
- female (1)
- filamin-C (1)
- flow dynamics (1)
- food consumption (1)
- free energy (1)
- free‐breathing (1)
- functional magnetic resonance imaging (1)
- functional mitral regurgitation (1)
- gene panel (1)
- genetics (1)
- giant intracranial aneurysm (1)
- glial damage (1)
- glomerular filtration rate (1)
- glucocorticoid replacement therapy (1)
- guideline-directed medical therapy (1)
- guidelines (1)
- haemodialysis (1)
- haemodynamic monitoring (1)
- healing and remodelling processes (1)
- health care (1)
- health policy (1)
- health-related quality of life (1)
- health‐related quality of life (1)
- heart disease (1)
- heart failure training group (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- heart rate variability (1)
- heart structure (1)
- heart valve bypass (1)
- hemodialysis (1)
- heterozygote (1)
- high-field MRI (1)
- hospitals (1)
- human behaviour (1)
- human induced pluripotent stem cells (hiPSC) (1)
- humans (1)
- iPSC-CMs (1)
- iPSC-cardiomyocytes (1)
- iPSC-derived CMs (iPSC-CMs) (1)
- image processing (1)
- images (1)
- imaging techniques (1)
- immune cells (1)
- immunohistochemistry (1)
- immunosenescence (1)
- implementation (1)
- in vitro model system of inherited cardiomyopathies (1)
- in vivo imaging (1)
- in-vivo (1)
- induced pluripotent stem cells (iPSCs) (1)
- infarction size (1)
- infection (1)
- inferior vena cava (1)
- inflammaging (1)
- inherited cardiomyopathies (1)
- insulin tolerance test (1)
- integrated stress response (1)
- intensity of attention (1)
- intensive care transport (1)
- interhospital transfer (1)
- intermediate filaments (1)
- interparticle interaction (1)
- ischemic-stroke (1)
- junctions (1)
- kidney (1)
- kidney function (1)
- lactic acidosis (1)
- large animal models (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular hypertrophy (1)
- left ventricular mass (1)
- left ventricular mass index (1)
- left ventricular performance (1)
- left ventricular remodeling (1)
- left ventricular thrombusv (1)
- left-ventricular function (1)
- lifestyle (1)
- linear regression analysis (1)
- long-term ventilation (1)
- low molecular heparin (1)
- lung (1)
- lymphocyte differentiation (1)
- lymphocytes (1)
- lysosomal storage disorders (1)
- m exercise training (1)
- mHealth (1)
- magnetic resoncance (1)
- major depression (1)
- management (1)
- matched filters (1)
- maturation strategies (1)
- mavacamten (1)
- meat (1)
- mechanisms (1)
- medical data integration center (1)
- medical informatics initiative (1)
- medical rehabilitation (1)
- meningioma (1)
- metabolism (1)
- metastasis (1)
- mice (1)
- middle aged (1)
- mild (1)
- mitochondria function and morphology (1)
- mitochondrial FAO (1)
- mitochondrial cardiomyopathy (1)
- mitochondrialer Ryanodin-Rezeptor (mRyR1) (1)
- mitotic genes (1)
- molecular biology (1)
- molecular imaging (1)
- molecular medicine (1)
- multivariate data analysis (1)
- music performance anxiety (1)
- mutations (1)
- myocardial aging (1)
- myocardial blood flow (1)
- myocardial perfusion reserve (1)
- myocardial work efficiency (1)
- myofilament proteins (1)
- myokardiale Arbeit (1)
- myosin (1)
- natriuretic peptide (1)
- nephrology (1)
- neuroblastoma (1)
- neurodevelopmental disorders / genetics (1)
- neuroendocrine neoplasms (NEN) (1)
- neuroendocrine tumors (NET) (1)
- neurofilament light chain (1)
- neuroinflammation (1)
- neurological (1)
- neurology (1)
- neuroscience (1)
- neurotrophins (1)
- next generation sequencing (1)
- nicotinamide nucleotide transhydrogenase (1)
- nnU-net (1)
- non-equilibrium thermodynamics (1)
- normal values (1)
- ollimator (1)
- omecamtiv mecarbil (1)
- on-site examination (1)
- oncology (1)
- openEHR (1)
- optimization (1)
- oral anticoagulants (1)
- organoid (1)
- outcomes (1)
- oxidative stress (1)
- pCa (1)
- percutaneous mitral valve repair (1)
- pharmacotherapy (1)
- phosphorylation (1)
- pig (1)
- pilot project (1)
- plaque characteristics (1)
- plasma proteins (1)
- population-based (1)
- post-reconstruction filtering (1)
- postmenopausal women (1)
- postoperative bleeding (1)
- poultry (1)
- power grids (1)
- progressive muscle relaxation (1)
- prostate cancer (1)
- prostate-specific membrane antigen (PSMA) (1)
- public health (1)
- pulmonary artery pressure (1)
- quantitative MRI (1)
- randomized controlled trial (1)
- real-world (1)
- recovery (1)
- reference data (1)
- rehabilitation (1)
- relaxometry (1)
- religion (1)
- remote monitoring (1)
- renal (1)
- renal function (1)
- research (1)
- research infrastructure (1)
- right heart impairment (1)
- right ventricular dysfunction (1)
- risk prediction scores (1)
- rumenic acid (1)
- sacubitril-valsartan (1)
- scanner (1)
- secondary data usage (1)
- self‐gated (1)
- semantic interoperability (1)
- semantic segmentation (1)
- sensitivity analysis (1)
- sex differences (1)
- shimming (1)
- short Synacthen test (1)
- sigma-1 receptor-directed molecular imaging (1)
- signal filtering (1)
- signal to noise ratio (1)
- six-minute walk test (1)
- skeletal (1)
- skinned fiber (1)
- small animal (1)
- small animal SPECT (1)
- small-animal imaging (1)
- social support (1)
- sodium-glucose co-transporter-2 inhibitors (1)
- somatostatin receptor (SSTR) (1)
- speckle tracking (1)
- speech recognition (1)
- sphingolipids (1)
- spin lock (1)
- spin-lock (1)
- spiral ganglion neuron (1)
- spironolactone (1)
- sports and exercise medicine (1)
- state space (1)
- statins (1)
- statistical data (1)
- statistical mechanics (1)
- stem cells (1)
- stem-cell research (1)
- stenosis (1)
- stepped impedance resonators (1)
- stroke (1)
- structure–activity relationships (1)
- study-group ADSR (1)
- sudden cardiac death (1)
- surgical aneurysm treatment (1)
- swine (1)
- sympathetic nervous system (1)
- systems biology (1)
- tandem peptide (1)
- targeted gene panel (1)
- therapy (1)
- therapy response (1)
- thermodynamics (1)
- thromboembolism (1)
- thrombolysis (1)
- time (1)
- trait emotional intelligence (1)
- transceiver array (1)
- transcription (1)
- transfer learning (1)
- transformations (1)
- transient ischemic attack (1)
- translational (1)
- ultrahigh field (1)
- ultrahigh-field (1)
- ultrahigh-field MRI (1)
- ultrasound (1)
- under-dosing (1)
- undersampling (1)
- urology (1)
- usability (1)
- user-centered design (1)
- vena contracta area (1)
- virtual reality exposure therapy (1)
- warfarin interruption (1)
- wave interference (1)
- wave‐CAIPI (1)
- weaning (1)
- zebrafish (1)
- Überleben (1)
- α-Ketoglutarate dehydrogenase (1)
- β1-adrenoceptor/β1-adrenergic receptor (1)
- βAR (1)
Institut
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (155) (entfernen)
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (2)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (1)
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäre Zentrum für Klinische Forschung (IZKF) (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) (1)
- Klinische Studienzentrale (Universitätsklinikum) (1)
- Servicezentrum Medizin-Informatik (1)
Arrhythmogenic cardiomyopathy (ACM) is an inherited heart muscle disease caused by heterozygous missense mutations within the gene encoding for the nuclear envelope protein transmembrane protein 43 (TMEM43). The disease is characterized by myocyte loss and fibro-fatty replacement, leading to life-threatening ventricular arrhythmias and sudden cardiac death. However, the role of TMEM43 in the pathogenesis of ACM remains poorly understood. In this study, we generated cardiomyocyte-restricted transgenic zebrafish lines that overexpress eGFP-linked full-length human wild-type (WT) TMEM43 and two genetic variants (c.1073C>T, p.S358L; c.332C>T, p.P111L) using the Tol2-system. Overexpression of WT and p.P111L-mutant TMEM43 was associated with transcriptional activation of the mTOR pathway and ribosome biogenesis, and resulted in enlarged hearts with cardiomyocyte hypertrophy. Intriguingly, mutant p.S358L TMEM43 was found to be unstable and partially redistributed into the cytoplasm in embryonic and adult hearts. Moreover, both TMEM43 variants displayed cardiac morphological defects at juvenile stages and ultrastructural changes within the myocardium, accompanied by dysregulated gene expression profiles in adulthood. Finally, CRISPR/Cas9 mutants demonstrated an age-dependent cardiac phenotype characterized by heart enlargement in adulthood. In conclusion, our findings suggest ultrastructural remodeling and transcriptomic alterations underlying the development of structural and functional cardiac defects in TMEM43-associated cardiomyopathy.
Functional magnetic resonance imaging (fMRI) has become a powerful and influential method to non-invasively study neuronal brain activity. For this purpose, the blood oxygenation level-dependent (BOLD) effect is most widely used. T2* weighted echo planar imaging (EPI) is BOLD sensitive and the prevailing fMRI acquisition technique. Here, we present an alternative to its standard Cartesian recordings, i.e. k-space density weighted EPI, which is expected to increase the signal-to-noise ratio in fMRI data. Based on in vitro and in vivo pilot measurements, we show that fMRI by k-space density weighted EPI is feasible and that this new acquisition technique in fact boosted spatial and temporal SNR as well as the detection of local fMRI activations. Spatial resolution, spatial response function and echo time were identical for density weighted and conventional Cartesian EPI. The signal-to-noise ratio gain of density weighting can improve activation detection and has the potential to further increase the sensitivity of fMRI investigations.
Functional versus morphological assessment of vascular age in patients with coronary heart disease
(2021)
Communicating cardiovascular risk based on individual vascular age (VA) is a well acknowledged concept in patient education and disease prevention. VA may be derived functionally, e.g. by measurement of pulse wave velocity (PWV), or morphologically, e.g. by assessment of carotid intima-media thickness (cIMT). The purpose of this study was to investigate whether both approaches produce similar results. Within the context of the German subset of the EUROASPIRE IV survey, 501 patients with coronary heart disease underwent (a) oscillometric PWV measurement at the aortic, carotid-femoral and brachial-ankle site (PWVao, PWVcf, PWVba) and derivation of the aortic augmentation index (AIao); (b) bilateral cIMT assessment by high-resolution ultrasound at three sites (common, bulb, internal). Respective VA was calculated using published equations. According to VA derived from PWV, most patients exhibited values below chronological age indicating a counterintuitive healthier-than-anticipated vascular status: for VA(PWVao) in 68% of patients; for VA\(_{AIao}\) in 52% of patients. By contrast, VA derived from cIMT delivered opposite results: e.g. according to VA\(_{total-cIMT}\) accelerated vascular aging in 75% of patients. To strengthen the concept of VA, further efforts are needed to better standardise the current approaches to estimate VA and, thereby, to improve comparability and clinical utility.
Die nicht-invasive Gefäßdiagnostik stellt einen wichtigen Pfeiler in der Prävention von Herz-Kreislauferkrankungen dar. Während lange Zeit die sonographische Messung der cIMT, als morphologisches Korrelat der Gefäßalterung, als Goldstandard galt, ist in den letzten Jahren in Gestalt der Pulswellenanalyse/PWV-Messung eine Technik weiterentwickelt worden, die, als funktionelles Korrelat der Gefäßalterung, aufgrund der leichteren Durchführbarkeit und geringerer Untersucherabhängigkeit und Kosten vielversprechend ist. So erlaubt die Messung der Pulswelle mittels gewöhnlicher Blutdruckmanschetten, genau wie die cIMT, die Berechnung des individuellen Gefäßalters und die Diagnostik für das Vorliegen eines Endorganschadens der Blutgefäße.
Um die Messergebnisse der beiden Untersuchungen miteinander zu vergleichen, wurden beide in der EUROASPIRE-IV Studie an Patienten mit koronarer Herzkrankheit durchgeführt. Die Auswertung der Messergebnisse der mit dem Vascular Explorer durchgeführten Pulswellenanalyse/PWV-Messung ergab überraschenderweise, dass die Mehrheit der herzkranken Patienten weder eine vaskuläre Voralterung noch einen Endorganschaden der Blutgefäße aufweisen. Im Falle der cIMT-Messung war Gegenteiliges der Fall, was trotz der medikamentösen Therapie der Patienten so zu erwarten war. Weiterhin zeigte sich lediglich eine geringe Korrelation zwischen den Messergebnissen beider Untersuchungen. Die Determinanten der einzelnen Messwerte aus cIMT und Pulswellenanalyse/PWV-Messung waren deckungsgleich mit den in der Literatur beschriebenen Faktoren, wenn auch viele der sonst signifikanten Regressoren das Signifikanzniveau in unserer Auswertung nicht unterschritten.
Eine Limitation der funktionellen Gefäßdiagnostik liegt derzeit darin, dass die Messergebnisse stark von dem verwendeten Messgerät abhängen. Es liegen noch zu wenig Vergleichsstudien vor, um die Messergebnisse, speziell von neueren Geräten wie dem Vascular Explorer, auf andere zu übertragen. Bei der Berechnung des Gefäßalters sollten daher optimalerweise gerätespezifische Normwerte vorliegen, was beim Vascular Explorer nicht der Fall ist. Gleiches gilt für die Verwendung des PWVcf-Grenzwerts für die Diagnose eines Endorganschadens der Blutgefäße.
Analog hat auch die Messung der cIMT gewisse Einschränkungen. So wäre eine weitere Standardisierung der Messorte (A. carotis communis vs Bulbus vs A. carotis interna), zwischen denen sich die durchschnittliche cIMT erheblich unterscheidet, sowie der Messparameter (Minimal- vs Maximal- vs Mittelwert) wünschenswert. Die universelle Anwendung eines cIMT-Grenzwerts zur Diagnose eines Endorganschadens der Blutgefäße ist daher kritisch zu sehen. Dies zeigt sich auch darin, dass in den neuesten Leitlinien der bislang geltende Grenzwert angezweifelt und kein aktuell gültiger Grenzwert mehr genannt wird.
Wir interpretieren unsere Ergebnisse dahingehend, dass unsere Messung der cIMT die zu erwartende pathologische Gefäßalterung bei Patienten mit koronarer Herzkrankheit besser widerspiegelt als die Messung der Pulswelle mit dem Vascular Explorer. Welche der beiden Untersuchungen hinsichtlich der prognostischen Wertigkeit überlegen ist, muss im Rahmen von Längsschnittstudien geklärt werden.
Aims
Chronic heart failure (CHF) can be caused by autoantibodies stimulating the heart via binding to first and/or second extracellular loops of cardiac β1-adrenoceptors. Allosteric receptor activation depends on conformational features of the autoantibody binding site. Elucidating these features will pave the way for the development of specific diagnostics and therapeutics. Our aim was (i) to fine-map the conformational epitope within the second extracellular loop of the human β\(_1\)-adrenoceptor (β1ECII) that is targeted by stimulating β\(_1\)-receptor (auto)antibodies and (ii) to generate competitive cyclopeptide inhibitors of allosteric receptor activation, which faithfully conserve the conformational auto-epitope.
Methods and results
Non-conserved amino acids within the β\(_1\)EC\(_{II}\) loop (compared with the amino acids constituting the ECII loop of the β\(_2\)-adrenoceptor) were one by one replaced with alanine; potential intra-loop disulfide bridges were probed by cysteine–serine exchanges. Effects on antibody binding and allosteric receptor activation were assessed (i) by (auto)antibody neutralization using cyclopeptides mimicking β1ECII ± the above replacements, and (ii) by (auto)antibody stimulation of human β\(_1\)-adrenoceptors bearing corresponding point mutations. With the use of stimulating β\(_1\)-receptor (auto)antibodies raised in mice, rats, or rabbits and isolated from exemplary dilated cardiomyopathy patients, our series of experiments unmasked two features of the β\(_1\)EC\(_{II}\) loop essential for (auto)antibody binding and allosteric receptor activation: (i) the NDPK\(^{211–214}\) motif and (ii) the intra-loop disulfide bond C\(^{209}\)↔C\(^{215}\). Of note, aberrant intra-loop disulfide bond C\(^{209}\)↔C\(^{216}\) almost fully disrupted the functional auto-epitope in cyclopeptides.
Conclusions
The conformational auto-epitope targeted by cardio-pathogenic β\(_1\)-receptor autoantibodies is faithfully conserved in cyclopeptide homologues of the β\(_1\)EC\(_{II}\) loop bearing the NDPK\(^{211–214}\) motif and the C\(^{209}\)↔C\(^{215}\) bridge while lacking cysteine C216. Such molecules provide promising tools for novel diagnostic and therapeutic approaches in β\(_1\)-autoantibodypositive CHF.
T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles governing Tpex maintenance and the regulatory circuits that control their exhaustion remain incompletely understood. Using a combination of gene-deficient mice, single-cell transcriptomics, and metabolomic analyses, we show that mitochondrial insufficiency is a cell-intrinsic trigger that initiates the functional exhaustion of T cells. At the molecular level, we find that mitochondrial dysfunction causes redox stress, which inhibits the proteasomal degradation of hypoxia-inducible factor 1α (HIF-1α) and promotes the transcriptional and metabolic reprogramming of Tpex cells into terminally exhausted T cells. Our findings also bear clinical significance, as metabolic engineering of chimeric antigen receptor (CAR) T cells is a promising strategy to enhance the stemness and functionality of Tpex cells for cancer immunotherapy.
Kognitive Beeinträchtigungen sind bei Patient*innen mit chronischer Herzinsuffizienz weit verbreitet. Auswertungen der Beobachtungsstudie „Cognition.Matters-HF“ konnten belegen, dass Patient*innen mit einer Herzschwäche häufig Gedächtnisstörungen und Aufmerksamkeitsdefizite aufweisen. Die Evidenz für einen Zusammenhang zwischen Kognition und Lebensqualität bei Herzinsuffizienz ist jedoch spärlich. Unser Ziel war es zu untersuchen, ob kognitive Einschränkungen Auswirkungen auf die Lebensqualität (HRQL) von Herzinsuffizienzpatient*innen haben. Anhand der Cognition.Matters-HF Kohorte untersuchten wir die HRQL von 148 Patient*innen mit chronischer Herzinsuffizienz und objektivierten kognitiven Beeinträchtigungen, die von keinen bis hin zu schweren Defiziten reichten. Die Lebensqualität der Teilnehmer*innen wurde über die beiden Selbstbeurteilungsfragebögen, Short Form-36 (SF-36) und Kansas City Cardiomyopathy Questionnaire (KCCQ), erfasst. Mit Ausnahme der Selbstwirksamkeitsskala des KCCQ war der Schweregrad der kognitiven Beeinträchtigung nicht mit Einschränkungen in der Lebensqualität bei Patient*innen mit chronischer Herzinsuffizienz verbunden. Der Zusammenhang zwischen Selbstwirksamkeit und Schweregrad der kognitiven Beeinträchtigung blieb auch nach Anpassung für Dauer und Schweregrad der Herzinsuffizienz, Alter und Geschlecht der Teilnehmer signifikant bestehen (p<0,001). Die Selbstwirksamkeitsskala stellt ein vielversprechendes Instrument dar, um Personen zu identifizieren, die nicht in der Lage sind, sich an ein empfohlenes, leitliniengerechtes Behandlungsschema für Herzinsuffizienz zu halten. Diese Patient*innen könnten von einer intensiveren Versorgung, z.B. im Rahmen eines von einer speziell geschulten Herzinsuffizienz-Schwester geleiteten Versorgungsprogramms, deutlich profitieren.
Genetic deficiency for acid sphingomyelinase or its pharmacological inhibition has been shown to increase Foxp3\(^+\) regulatory T-cell frequencies among CD4\(^+\) T cells in mice. We now investigated whether pharmacological targeting of the acid sphingomyelinase, which catalyzes the cleavage of sphingomyelin to ceramide and phosphorylcholine, also allows to manipulate relative CD4\(^+\) Foxp3\(^+\) regulatory T-cell frequencies in humans. Pharmacological acid sphingomyelinase inhibition with antidepressants like sertraline, but not those without an inhibitory effect on acid sphingomyelinase activity like citalopram, increased the frequency of Foxp3\(^+\) regulatory T cell among human CD4\(^+\) T cells in vitro. In an observational prospective clinical study with patients suffering from major depression, we observed that acid sphingomyelinase-inhibiting antidepressants induced a stronger relative increase in the frequency of CD4\(^+\) Foxp3\(^+\) regulatory T cells in peripheral blood than acid sphingomyelinase-non- or weakly inhibiting antidepressants. This was particularly true for CD45RA\(^-\) CD25\(^{high}\) effector CD4\(^+\) Foxp3\(^+\) regulatory T cells. Mechanistically, our data indicate that the positive effect of acid sphingomyelinase inhibition on CD4\(^+\) Foxp3\(^+\) regulatory T cells required CD28 co-stimulation, suggesting that enhanced CD28 co-stimulation was the driver of the observed increase in the frequency of Foxp3+ regulatory T cells among human CD4\(^+\) T cells. In summary, the widely induced pharmacological inhibition of acid sphingomyelinase activity in patients leads to an increase in Foxp3+ regulatory T-cell frequencies among CD4\(^+\) T cells in humans both in vivo and in vitro.
The Quality of Acute Stroke Care-an Analysis of Evidence-Based Indicators in 260 000 Patients
(2014)
Background: Stroke patients should be cared for in accordance with evidence-based guidelines. The extent of implementation of guidelines for the acute care of stroke patients in Germany has been unclear to date. Methods: The regional quality assurance projects that cooperate in the framework of the German Stroke Registers Study Group (Arbeitsgemeinschaft Deutscher Schlaganfall-Register, ADSR) collected data on the care of stroke patients in 627 hospitals in 2012. The quality of the acute hospital care of patients with stroke or transient ischemic attack (TIA) was assessed on the basis of 15 standardized, evidence-based quality indicators and compared across the nine participating regional quality assurance projects. Results: Data were obtained on more than 260 000 patients nationwide. Intravenous thrombolysis was performed in 59.7% of eligible ischemic stroke patients patients (range among participating projects, 49.7-63.6%). Dysphagia screening was documented in 86.2% (range, 74.8-93.1%). For the following indicators, the defined targets were not reached for all of Germany: antiaggregation within 48 hours, 93.4% (range, 86.6-96.4%); anticoagulation for atrial fibrillation, 77.6% (range, 72.4-80.1%); standardized dysphagia screening, 86.2% (range, 74.8-93.1%); oral and written information of the patients or their relatives, 86.1% (range, 75.4-91.5%). The rate of patients examined or treated by a speech therapist was in the target range. Conclusion: The defined targets were reached for most of the quality indicators. Some indicators, however, varied widely across regional quality assurance projects. This implies that the standardization of care for stroke patients in Germany has not yet been fully achieved.
We aimed to determine a detailed regional ventricular distribution pattern of the novel cardiac nerve PET radiotracer \(^{18}\)F-LMI1195 in healthy rabbits. Ex-vivo high resolution autoradiographic imaging was conducted to identify accurate ventricular distribution of \(^{18}\)F-LMI1195. In healthy rabbits, \(^{18}\)F-LMI1195 was administered followed by the reference perfusion marker \(^{201}\)Tl for a dual-radiotracer analysis. After 20 min of \(^{18}\)F-LMI1195 distribution time, the rabbits were euthanized, the hearts were extracted, frozen, and cut into 20-μm short axis slices. Subsequently, the short axis sections were exposed to a phosphor imaging plate to determine \(^{18}\)F-LMI1195 distribution (exposure for 3 h). After complete \(^{18}\)F decay, sections were re-exposed to determine 201Tl distribution (exposure for 7 days). For quantitative analysis, segmental regions of Interest (ROIs) were divided into four left ventricular (LV) and a right ventricular (RV) segment on mid-ventricular short axis sections. Subendocardial, mid-portion, and subepicardial ROIs were placed on the LV lateral wall. \(^{18}\)F-LMI1195 distribution was almost homogeneous throughout the LV wall without any significant differences in all four LV ROIs (anterior, posterior, septal and lateral wall, 99 ± 2, 94 ± 5, 94 ± 4 and 97 ± 3%LV, respectively, n.s.). Subepicardial \(^{201}\)Tl uptake was significantly lower compared to the subendocardial portion (subendocardial, mid-portion, and subepicardial activity: 90 ± 3, 96 ± 2 and *80 ± 5%LV, respectively, *p < 0.01 vs. mid-portion). This was in contradistinction to the transmural wall profile of \(^{18}\)F-LMI1195 (90 ± 4, 96 ± 5 and 84 ± 4%LV, n.s.). A slight but significant discrepant transmural radiotracer distribution pattern of \(^{201}\)Tl in comparison to \(^{18}\)F-LMI1195 may be a reflection of physiological sympathetic innervation and perfusion in rabbit hearts.
Tracing its roots back to the 1940s, theranostics in nuclear oncology has proved successful mainly due to the beneficial effects of image-guided therapeutic concepts for patients afflicted with a variety of different cancers. The majority of these treatments are not only characterized by substantial prolongation of progression-free and overall survival, but are also generally safe, rendering theranostic agents as an attractive treatment option in various clinical scenarios in oncology. In this Special Issue Novel Theranostic Agents, nine original articles from around the globe provide further evidence on the use of the theranostic concept for neuroendocrine neoplasm (NEN), prostate cancer (PC), meningioma, and neuroblastoma. The investigated diagnostic and therapeutic radiotracers target not only established structures, such as somatostatin receptor, prostate-specific membrane antigen or norepinephrine transporter, but also recently emerging targets such as the C-X-C motif chemokine receptor 4. Moreover, the presented original articles also combine the concept of theranostics with in-depth read-out techniques such as radiomics or novel reconstruction algorithms on pretherapeutic scans, e.g., for outcome prediction. Even 80 years after its initial clinical introduction, theranostics in oncology continues to thrive, now more than ever.
Frequenzabhängigkeit der IP3-induzierten Calciumregulation in murinen ventrikulären Kardiomyozyten
(2023)
In Kardiomyozyten ist Calcium (Ca2+) ein wichtiges Signalmolekül und eine präzise Regulation der Ca2+ Konzentration in den Zellkompartimenten erforderlich. Ca2+ wird Angiotensin II-induziert und vom Botenstoff IP3 vermittelt aus IP3 Rezeptoren des Sarkoplasmatischen Retikulum (SR) freigesetzt, was zur mitochondrialen Ca2+ Aufnahme führt. Diese Kommunikationswege zwischen SR und Mitochondrium sind u.a. bei der Herzinsuffizienz durch pathologische Umbauprozesse gestört. Zudem zirkulieren bei Herzinsuffizienz vermehrt Hormone wie AngII, welches u.a. die intrazelluläre IP3 Konzentration steigert und als Hypertrophie Signal wirkt. Dieser Arbeit geht die Vermutung voraus, dass eine gestörte mitochondriale Ca2+ Aufnahme durch Veränderung des nukleären Ca2+ Transienten die hypertrophe Genexpression beeinflussen kann. Es wurde an ventrikulären Kardiomyozyten von adulten Mäusen mit kardiospezifischem MCU Knock out oder MCU Wildtyp untersucht, wie sich Ca2+ Transienten in Zytosol und Nukleus bei AngII-Stimulation und Störung der mitochondrialen Ca2+ Aufnahme durch Blockade des mRyR1 oder des MCU verändern. Zum Vergleich wurde der Effekt des β adrenerg vermittelten, IP3 unabhängigen Ca2+ Anstiegs beobachtet. Zur Untersuchung der Frequenzabhängigkeit der Effekte wurde die elektrische Stimulation wurde variiert. Die Arbeit zeigt, dass sich die Blockade der mitochondrialen Ca2+ Aufnahme unterschiedlich auf den nukleären Ca2+ Transienten auswirkt: Bei AngII-Stimulation kam es in Folge der Blockade des mRyR1, nicht aber des MCU, zur Steigerung des nukleären Ca2+ Transienten. Dieser Effekt war bei 1 Hz Stimulationsfrequenz, nicht aber nach einer Steigerung auf 4 Hz zu beobachten. Bei β adrenerger Stimulation hingegen veränderte die Blockade des MCU oder des mRyR1 die Ca2+ Transienten im Kern nicht signifikant. Die Arbeit verdeutlicht die Bedeutung der IP3 vermittelten Ca2+ Freisetzung für die Kontrolle der Ca2+ Konzentrationen in unterschiedlichen zellulären Kompartimenten.
Psychosocial factors affect mental health and health-related quality of life (HRQL) in a complex manner, yet gender differences in these interactions remain poorly understood. We investigated whether psychosocial factors such as social support and personal and work-related concerns impact mental health and HRQL differentially in women and men during the first year of the COVID-19 pandemic. Between June and October 2020, the first part of a COVID-19-specific program was conducted within the “Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB)” cohort study, a representative age- and gender-stratified sample of the general population of Würzburg, Germany. Using psychometric networks, we first established the complex relations between personal social support, personal and work-related concerns, and their interactions with anxiety, depression, and HRQL. Second, we tested for gender differences by comparing expected influence, edge weight differences, and stability of the networks. The network comparison revealed a significant difference in the overall network structure. The male (N = 1370) but not the female network (N = 1520) showed a positive link between work-related concern and anxiety. In both networks, anxiety was the most central variable. These findings provide further evidence that the complex interplay of psychosocial factors with mental health and HRQL decisively depends on gender. Our results are relevant for the development of gender-specific interventions to increase resilience in times of pandemic crisis.
Patients with genetic cardiomyopathy that involves myocardial hypertrophy often develop clinically relevant arrhythmias that increase the risk of sudden death. Consequently, guidelines for medical device therapy were established for hypertrophic cardiomyopathy, but not for conditions with only anecdotal evidence of arrhythmias, like Fabry cardiomyopathy. Patients with Fabry cardiomyopathy progressively develop myocardial fibrosis, and sudden cardiac death occurs regularly. Because 24-hour Holier electrocardiograms (ECGs) might not detect clinically important arrhythmias, we tested an implanted loop recorder for continuous heart rhythm surveillance and determined its impact on therapy. This prospective study included 16 patients (12 men) with advanced Fabry cardiomyopathy, relevant hypertrophy, and replacement fibrosis in "loco typico." No patients previously exhibited clinically relevant arrhythmias on Holier ECGs. Patients received an implantable loop recorder and were prospectively followed with telemedicine for a median of 1.2 years (range 0.3 to 2.0 years). The primary end point was a clinically meaningful event, which required a therapy change, captured with the loop recorder. Patients submitted data regularly (14 +/- 11 times per month). During follow-up, 21 events were detected (including 4 asystole, i.e., ECG pauses >= 3 seconds) and 7 bradycardia events; 5 episodes of intermittent atrial fibrillation (>3 minutes) and 5 episodes of ventricular tachycardia (3 sustained and 2 nonsustained). Subsequently, as defined in the primary end point, 15 events leaded to a change of therapy. These patients required therapy with a pacemaker or cardioverter defibrillator implantation and/or anticoagulation therapy for atrial fibrillation. In conclusion, clinically relevant arrhythmias that require further device and/or medical therapy are often missed with Holier ECGs in patients with advanced stage Fabry cardiomyopathy, but they can be detected by telemonitoring with an implantable loop recorder.
We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-directed positron emission tomography (PET) tracer \(^{68}\)Ga-Pentixafor in patients with poorly differentiated neuroendocrine carcinomas (NEC), relative to the established reference standard \(^{18}\)F-FDG PET/computed tomography (CT). In our database, we retrospectively identified 11 treatment-naïve patients with histologically proven NEC, who underwent \(^{18}\)F-FDG and CXCR4-directed PET/CT for staging and therapy planning. The images were analyzed on a per-patient and per-lesion basis and compared to immunohistochemical staining (IHC) of CXCR4 from PET-guided biopsies. \(^{68}\)Ga-Pentixafor visualized tumor lesions in 10/11 subjects, while \(^{18}\)F-FDG revealed sites of disease in all 11 patients. Although weak to moderate CXCR4 expression could be corroborated by IHC in 10/11 cases, \(^{18}\)F-FDG PET/CT detected significantly more tumor lesions (102 vs. 42; total lesions, n = 107; p < 0.001). Semi-quantitative analysis revealed markedly higher 18F-FDG uptake as compared to \(^{68}\)Ga-Pentixafor (maximum and mean standardized uptake values (SUV) and tumor-to-background ratios (TBR) of cancerous lesions, SUVmax: 12.8 ± 9.8 vs. 5.2 ± 3.7; SUVmean: 7.4 ± 5.4 vs. 3.1 ± 3.2, p < 0.001; and, TBR 7.2 ± 7.9 vs. 3.4 ± 3.0, p < 0.001). Non-invasive imaging of CXCR4 expression in NEC is inferior to the reference standard \(^{18}\)F-FDG PET/CT.
Purpose
Image acquisition and subsequent manual analysis of cardiac cine MRI is time-consuming. The purpose of this study was to train and evaluate a 3D artificial neural network for semantic segmentation of radially undersampled cardiac MRI to accelerate both scan time and postprocessing.
Methods
A database of Cartesian short-axis MR images of the heart (148,500 images, 484 examinations) was assembled from an openly accessible database and radial undersampling was simulated. A 3D U-Net architecture was pretrained for segmentation of undersampled spatiotemporal cine MRI. Transfer learning was then performed using samples from a second database, comprising 108 non-Cartesian radial cine series of the midventricular myocardium to optimize the performance for authentic data. The performance was evaluated for different levels of undersampling by the Dice similarity coefficient (DSC) with respect to reference labels, as well as by deriving ventricular volumes and myocardial masses.
Results
Without transfer learning, the pretrained model performed moderately on true radial data [maximum number of projections tested, P = 196; DSC = 0.87 (left ventricle), DSC = 0.76 (myocardium), and DSC =0.64 (right ventricle)]. After transfer learning with authentic data, the predictions achieved human level even for high undersampling rates (P = 33, DSC = 0.95, 0.87, and 0.93) without significant difference compared with segmentations derived from fully sampled data.
Conclusion
A 3D U-Net architecture can be used for semantic segmentation of radially undersampled cine acquisitions, achieving a performance comparable with human experts in fully sampled data. This approach can jointly accelerate time-consuming cine image acquisition and cumbersome manual image analysis.
Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies
(2020)
The heart is the most energy-consuming organ in the human body. In heart failure, the homeostasis of energy supply and demand is endangered by an increase in cardiomyocyte workload, or by an insufficiency in energy-providing processes. Energy metabolism is directly associated with mitochondrial redox homeostasis. The production of toxic reactive oxygen species (ROS) may overwhelm mitochondrial and cellular ROS defense mechanisms in case of heart failure. Mitochondria are essential cell organelles and provide 95% of the required energy in the heart. Metabolic remodeling, changes in mitochondrial structure or function, and alterations in mitochondrial calcium signaling diminish mitochondrial energy provision in many forms of cardiomyopathy. The mitochondrial respiratory chain creates a proton gradient across the inner mitochondrial membrane, which couples respiration with oxidative phosphorylation and the preservation of energy in the chemical bonds of ATP. Akin to other mitochondrial enzymes, the respiratory chain is integrated into the inner mitochondrial membrane. The tight association with the mitochondrial phospholipid cardiolipin (CL) ensures its structural integrity and coordinates enzymatic activity. This review focuses on how changes in mitochondrial CL may be associated with heart failure. Dysfunctional CL has been found in diabetic cardiomyopathy, ischemia reperfusion injury and the aging heart. Barth syndrome (BTHS) is caused by an inherited defect in the biosynthesis of cardiolipin. Moreover, a dysfunctional CL pool causes other types of rare inherited cardiomyopathies, such as Sengers syndrome and Dilated Cardiomyopathy with Ataxia (DCMA). Here we review the impact of cardiolipin deficiency on mitochondrial functions in cellular and animal models. We describe the molecular mechanisms concerning mitochondrial dysfunction as an incitement of cardiomyopathy and discuss potential therapeutic strategies.
In heart failure, a functional block of complex I of the respiratory chain provokes superoxide generation, which is transformed to H\(_2\)O\(_2\) by dismutation. The Krebs cycle produces NADH, which delivers electrons to complex I, and NADPH for H\(_2\)O\(_2\) elimination via isocitrate dehydrogenase and nicotinamide nucleotide transhydrogenase (NNT). At high NADH levels, α-ketoglutarate dehydrogenase (α-KGDH) is a major source of superoxide in skeletal muscle mitochondria with low NNT activity. Here, we analyzed how α-KGDH and NNT control H\(_2\)O\(_2\) emission in cardiac mitochondria. In cardiac mitochondria from NNT-competent BL/6N mice, H\(_2\)O\(_2\) emission is equally low with pyruvate/malate (P/M) or α-ketoglutarate (α-KG) as substrates. Complex I inhibition with rotenone increases H2O2 emission from P/M, but not α-KG respiring mitochondria, which is potentiated by depleting H\(_2\)O\(_2\)-eliminating capacity. Conversely, in NNT-deficient BL/6J mitochondria, H2O2 emission is higher with α-KG than with P/M as substrate, and further potentiated by complex I blockade. Prior depletion of H\(_2\)O\(_2\)-eliminating capacity increases H\(_2\)O\(_2\) emission from P/M, but not α-KG respiring mitochondria. In cardiac myocytes, downregulation of α-KGDH activity impaired dynamic mitochondrial redox adaptation during workload transitions, without increasing H\(_2\)O\(_2\) emission. In conclusion, NADH from α-KGDH selectively shuttles to NNT for NADPH formation rather than to complex I of the respiratory chain for ATP production. Therefore, α-KGDH plays a key role for H\(_2\)O\(_2\) elimination, but is not a relevant source of superoxide in heart. In heart failure, α-KGDH/NNT-dependent NADPH formation ameliorates oxidative stress imposed by complex I blockade. Downregulation of α-KGDH may, therefore, predispose to oxidative stress in heart failure.
Background: Impairments of health related quality of life (HRQoL) are frequently observed in Fabry disease (FD) and are known to be related to neuropathic pain and cardiovascular events. This study aimed to explore the role of chronic kidney disease (CKD) in a large cohort of patients with FD.
Methods: In 96 patients (53% female; age 40 ± 12 yrs) with genetically proven FD, HRQoL was assessed by the Medical Outcomes Study (SF-36) questionnaire. All patients were naïve to enzyme replacement therapy. Three categories for kidney dysfunction were chosen, eGFR ≥/<60 ml/min/1.73 m2 or need of renal replacement therapy (RRT). Minor (e.g. arrhythmia, angina pectoris, etc.) and major (e.g. myocardial infarction, coronary artery bypass, stroke or implantable cardioverter-defibrillator) vascular events as well as pain and pain therapy were considered in linear regression analyses with the dimensions of HRQoL.
Results: Ten patients (10%) had impaired kidney function and a further nine were on RRT (9.4%). Kidney function and pain emerged as the main factors associated with lower scores on the SF 36, in particular on physical components (PCS beta-coefficients for CKD −6.2, for RRT −11.8, for pain −9.1, p < 0.05, respectively), while controlling for gender, vascular event and pain-therapy. Relationships were found for mental aspects of HRQoL. Age and history of vascular events were not related to HRQoL.
Conclusion: Cardiovascular events and pain are important factors related to HRQoL, social functioning and depression. Our study highlights impaired chronic kidney disease, in particular after initiation of RRT, as a strong determinant of reduced HRQoL in FD.
Kationenkanäle der Canonical Transient Receptor (TRPC)-Familie spielen eine wichtige Rolle in der pathologischen Herzhypertrophie. Neben anderen Isoformen besitzt TRPC4 die Potenz, den strukturellen und funktionellen Umbau des Herzens im Rahmen der pathologischen Hypertrophie über Ca2+-Transienten zu bestärken. TRPC4-Kanäle sind nicht-selektive Kationenkanäle, die für Na+ und Ca2+ durchlässig sind. Sie setzen sich in der Plasmamembran zu Homo- oder Heterotetrameren zusammen. Die TRPC4-Kanalaktivität wird durch die Stimulation von Gq-Protein-gekoppelten Rezeptoren (GPCR) reguliert und führt zu einem Ca2+-Einstrom, der für die Aktivierung von Calcineurin und des nuclear factor of activated T-cells (NFAT) notwendig ist. Eine weitere Aktivierungsform lässt sich über die Entleerung von intrazellulären Ca2+-Speichern (SOCE) aus dem Sarkoplasmatischen Retikulum (SR) nachweisen. Die funktionelle Wirkung des TRPC4 ist von der Expression der beiden Splice-Varianten TRPC4α und TRPC4β abhängig.
Um diese funktionelle Abhängigkeit der Splice-Variante C4β genauer zu charakterisieren, wurden in der vorliegenden Studie zytosolische Ca2+-Signale und deren Aktivierungsmechanismen analysiert. Für die Untersuchungen wurden neonatale Rattenkardiomyozyten (NRC) verwendet, die mit adenoviralen Vektoren infiziert wurden und TRPC4beta (Ad-TRPC4β), TRPC4alpha (Ad-TRPC4α) und beta-Galaktosidase (Ad-ßgal) als Kontrolle exprimierten. Es erfolgte eine Auswertung der Ca2+-Transienten, in der gezeigt werden konnte, dass TRPC4β den Ca2+-Einstrom in schlagenden Kardiomyozyten beeinflusst. Dies machte sich in einer erhöhten Ca2+-Amplitude unter basalen Bedingungen bemerkbar. Ebenfalls konnte deutlich gemacht werden, dass eine Ca2+-Entleerung des SR TRPC4β als sogenannten SOC (speicher-regulierten Kanal, store-operated channel) aktiviert. Außerdem reagierten TRPC4β-infizierte NRCs mit einem gesteigerten Ca2+-Maximalspitzenwert (peak) unter Stimulation mit dem GPCR-Agonisten Angiotensin II. Die Amplitude der Ca2+-Transienten bei Überexpression von Ad-TRPC4β war im Vergleich zur Ad-ßgal-Kontrollgruppe deutlich gesteigert. Darüber hinaus war der Abfall der Ca2+-Transienten der TRPC4β-exprimierenden Zellen beschleunigt. Dies lässt einen kompensatorischen Mechanismus vermuten, mit dem Ziel, einer Ca2+-Überladung der Zelle durch den TRPC4β-induzierten Ca2+-Einstrom entgegenzuwirken. In zusätzlichen Experimenten zeigte sich TRPC4β ebenfalls deutlich sensitiver gegenüber der Angiotensin II-Stimulation als TRPC4α. Weiterführende Untersuchungen ließen erkennen, dass TRPC4β, im Gegensatz zu anderen TRPC-Isoformen, keinen pro-hypertrophen, sondern vielmehr einen pro-apoptotischen Einfluss auf Kardiomyozyten ausübt.
Zusammenfassend zeigt die vorliegende Studie, dass eine erhöhte Aktivität der Splice-Variante TRPC4β mit kritischen Veränderungen zytosolischer Ca2+-Signale verbunden ist und somit ein entscheidender Faktor für die Entstehung und Progression kardialer Pathologien sein könnte.